Compounding pharmacies to halt semaglutide sales May 22

Come May 22, compounding pharmacies must stop making semaglutide injections, which serve as a more affordable generic alternative to Ozempic and Wegovy. This decision follows a judge's denial of the pharmacies' request to continue selling the formulation.